Medartis Holding AGXSWX:MED +4.28%82 PEG Ratio is 7.46 as of Jun. 28, 2026, which is 50% below its 10-year median of 15.07. GuruFocus rates XSWX:MED with a GF Score™ of 82/100 and a GF Value™ of CHF105.66 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 207 Medical Devices & Instruments companies, Medartis Holding AG ranks worse than 87.92% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Medartis Holding AG's PEG Ratio or its related term are showing as below:
XSWX:MED'
s PEG Ratio Range Over the Past 10 Years
Min: 5.88 Med: 15.07 Max: 31.49
Current: 7.46
During the past 12 years, Medartis Holding AG's highest PEG Ratio was 31.49. The lowest was 5.88. And the median was 15.07.
XSWX:MED's PEG Ratio is ranked worse than 87.92% of 207
companies
in the Medical Devices & Instruments industry
Industry Median: 2.03
vs XSWX:MED: 7.46
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Medartis Holding AG (XSWX:MED) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Medartis Holding AG PEG Ratio Related Terms
Medartis Holding AG PEG Ratio Historical Data
* Premium members only.
The historical data trend for Medartis Holding AG's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Medartis Holding AG's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medartis Holding AG PEG Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medartis Holding AG's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Medartis Holding AG's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Medartis Holding AG (XSWX:MED) has a PEG Ratio of 7.46 as of Jun. 28, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Medartis Holding AG and its competitors. This is 50% below median its historical median of 15.07. Over the past decade, Medartis Holding AG's PEG Ratio has ranged from 5.88 to 31.49. According to the industry distribution chart, Medartis Holding AG ranks #182 out of 207 companies in the Medical Devices & Instruments industry, placing it in the top 87.9%.
Is Medartis Holding AG's PEG Ratio too high?
Medartis Holding AG's current PEG Ratio of 7.46 is 50% below median its 10-year median of 15.07. Over the past 10 years, this metric has ranged from a low of 5.88 to a high of 31.49. The Medical Devices & Instruments industry median PEG Ratio is 2.03. Medartis Holding AG's value of 7.46 is 267.5% above this industry median. Based on the distribution chart, Medartis Holding AG ranks #182 out of 207 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Medartis Holding AG has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medartis Holding AG's PEG Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medartis Holding AG ranks #182 out of 207 companies for PEG Ratio. This places Medartis Holding AG in the lower half of its industry. The industry median PEG Ratio is 2.03. Medartis Holding AG's value of 7.46 is 267.5% above this benchmark. Historically, Medartis Holding AG's own PEG Ratio has ranged from 5.88 to 31.49 over the past decade. While the company's 10-year median is 15.07 vs. the industry median of 2.03, Medartis Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Devices & Instruments company?
The median PEG Ratio among Medical Devices & Instruments companies is 2.03, based on 207 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medartis Holding AG's current PEG Ratio of 7.46 is 267.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Medartis Holding AG and its competitors. For the Medical Devices & Instruments industry, the median PEG Ratio is 2.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medartis Holding AG's current PEG Ratio is 7.46, which is 50% below median its own 10-year median of 15.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medartis Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Medartis Holding AG (XSWX:MED) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF105.66, compared to a current price of CHF80.40 — trading 23.9% below its estimated fair value. The current PEG Ratio is 7.46, which is 50% below median its 10-year median of 15.07 and 267.5% above the Medical Devices & Instruments industry median of 2.03. Medartis Holding AG's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Medartis Holding AG (XSWX:MED), the current PEG Ratio is 7.46 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medartis Holding AG (XSWX:MED) Overvalued in 2026?
Based on GuruFocus' analysis, Medartis Holding AG stock appears to be undervalued.
The current stock price of CHF80.40 is trading 23.9% below its estimated GF Value™ of CHF105.66.
GuruFocus considers Medartis Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:MED:
PEG Ratio: 7.46 (50% below median its 10-year median of 15.07)
GF Value™: CHF105.66 vs. price of CHF80.40 (23.9% below fair value)
Industry Position: 267.5% above the Medical Devices & Instruments median (#182 of 207)
No single metric tells the full story. See the XSWX:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products, StealthFix Products, and MODUS products. APTUS includes products for the Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for the mandible. Geographically, it derives the majority of its revenue from Europe, Middle East and Africa (EMEA) and also has a presence in North America, Asia Pacific, and Latin America.
82GF Score
Get the complete analysis for XSWX:MED
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:MED has been successfully added to your 
